4 research departments
750 employees
45 nationalities
55 research teams
16 ERC laureates
260 publications per year
24000 m² lab area

Support us through

Fondation universite de Strasbourg



Tel. : +33 (0)3 88 65 33 12

Key figures

52 research teams
131 researchers
37 post-doctoral fellows
72 PhD students
121 engineers & technicians
113 administrators & general services 110 ICS employees

Quick Links

Job opportunities

Mechanisms Of Neonatal Diabetes And Intestinal Deficiencies In Mitchell-Riley Syndrome

Reference : PhD Gérard Gradwohl

Offer publication : Jan. 26, 2018

Mutations in single genes can lead to rare, early-onset, forms of diabetes defined as monogenic diabetes which include Neonatal Diabetes Mellitus. These rare forms of diabetes result from mutations in genes controlling pancreatic beta cell (producing insulin) development and/or function. Recently, mutations in the winged helix transcription factor RFX6 have been identified in patients diagnosed with Mitchell-Riley syndrome characterized by neonatal diabetes and gastro-intestinal defects (Smith et al, Nature 2010).


Our Studies in mice revealed that Rfx6 is essential for islet cell maturation in the embryo (Soyer et al, Development 2010) and beta cell function in the adult (Piccand et al. Cell Reports 2014). However, the mechanisms leading to the lack of glucagon and insulin hormones in alpha and beta cell at birth, as well as to intestinal deficiencies in patients and mice lacking Rfx6 are not understood. 


Therefore, the goal of this project is to decipher the pathogenesis of Mitchell-Riley syndrome by disease modeling in mice and human culture systems using engineered induced pluripotent stem cells (hiPSC) derived pancreatic islet cells and intestinal organoids.

Your application

Application Deadline : Nov. 1, 2018

Imprimer Envoyer

Université de Strasbourg

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr